Exelixis
EXEL
#1573
Rank
NZ$24.27 B
Marketcap
NZ$96.59
Share price
0.02%
Change (1 day)
29.94%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company